Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ram

Showing results (211-220 of 24,158) with videos related to

Pageof 2,416
Sort By:
ACS Medicinal Chemistry Letters|December 20, 2023
Novel Pyrido[3,2-<i>d</i>]pyrimidines as HPK1 Inhibitors for Treating Cancer and Inflammatory and Autoimmune DiseasesRam W Sabnis
ACS Medicinal Chemistry Letters|December 20, 2023
Novel Fused Pyrazole Amide Analogs as Glucosylceramide Synthase Inhibitors for Treating Lysosomal Storage Diseases, Neurodegenerative Diseases, Cystic Diseases, and CancerRam W Sabnis
ACS Medicinal Chemistry Letters|December 20, 2023
Novel Pyrrole Derivatives as Apolipoprotein L-1 Inhibitors for Treating Kidney Diseases and SepsisRam W Sabnis
ACS Medicinal Chemistry Letters|January 17, 2024
Sulfonamide Compounds as Orexin Receptor Agonists for Treating Sleep Disorders, Namely, Narcolepsy and HypersomniaRam W Sabnis
ACS Medicinal Chemistry Letters|March 20, 2024
Novel Heterocyclic PAD4 Inhibitors for Treating DiseasesRam W Sabnis
ACS Medicinal Chemistry Letters|March 20, 2024
Combination of Allosteric and Orthosteric EGFR Inhibitors for Treating Non-Small-Cell Lung CancerRam W Sabnis
ACS Medicinal Chemistry Letters|September 18, 2024
MALT1 Inhibitors for Treating Cancer and Immunological DiseasesRam W Sabnis
ACS Medicinal Chemistry Letters|February 14, 2024
Novel Heterocyclic PAD4 Inhibitors for Treating Multiple DiseasesRam W Sabnis
ACS Medicinal Chemistry Letters|February 14, 2024
Novel Fused Triazole Compounds as RIPK1 Inhibitors for Treating Neurodegenerative, Autoimmune, and Inflammatory DiseasesRam W Sabnis
Cutis|July 5, 2023
Inpatient Dermatology Consultation Services in Hospital InstitutionsDev Ram Sahni
Pageof 2,416

Showing results (211-220 of 24,158) with videos related to

Sort By:
Pageof 2,416
ACS Medicinal Chemistry Letters|December 20, 2023
Novel Pyrido[3,2-<i>d</i>]pyrimidines as HPK1 Inhibitors for Treating Cancer and Inflammatory and Autoimmune DiseasesRam W Sabnis
ACS Medicinal Chemistry Letters|December 20, 2023
Novel Fused Pyrazole Amide Analogs as Glucosylceramide Synthase Inhibitors for Treating Lysosomal Storage Diseases, Neurodegenerative Diseases, Cystic Diseases, and CancerRam W Sabnis
ACS Medicinal Chemistry Letters|December 20, 2023
Novel Pyrrole Derivatives as Apolipoprotein L-1 Inhibitors for Treating Kidney Diseases and SepsisRam W Sabnis
ACS Medicinal Chemistry Letters|January 17, 2024
Sulfonamide Compounds as Orexin Receptor Agonists for Treating Sleep Disorders, Namely, Narcolepsy and HypersomniaRam W Sabnis
ACS Medicinal Chemistry Letters|March 20, 2024
Novel Heterocyclic PAD4 Inhibitors for Treating DiseasesRam W Sabnis
ACS Medicinal Chemistry Letters|March 20, 2024
Combination of Allosteric and Orthosteric EGFR Inhibitors for Treating Non-Small-Cell Lung CancerRam W Sabnis
ACS Medicinal Chemistry Letters|September 18, 2024
MALT1 Inhibitors for Treating Cancer and Immunological DiseasesRam W Sabnis
ACS Medicinal Chemistry Letters|February 14, 2024
Novel Heterocyclic PAD4 Inhibitors for Treating Multiple DiseasesRam W Sabnis
ACS Medicinal Chemistry Letters|February 14, 2024
Novel Fused Triazole Compounds as RIPK1 Inhibitors for Treating Neurodegenerative, Autoimmune, and Inflammatory DiseasesRam W Sabnis
Cutis|July 5, 2023
Inpatient Dermatology Consultation Services in Hospital InstitutionsDev Ram Sahni
Pageof 2,416